Your session is about to expire
← Back to Search
Written Exposure for Cancer
Study Summary
This trial seeks to understand how cancer patients can benefit from a writing-based intervention to help address their worst fears about cancer.
- Post-Traumatic Stress Disorder
- Cancer
- Cancer Phobia
- Anxiety
- Lymphoproliferative Disorders
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there opportunities for patients to join this research endeavor?
"Clinicialtrials.gov has published that this clinical trial is still seeking volunteers, with the original posting taking place on April 18th 2022 and the most recent edit being made on September 13th 2023."
How many individuals are currently being enrolled in this research project?
"Affirmative. The online listing on clinicaltrials.gov specifies that this medical trial is open to recruitment and was initially published on April 18th 2022, most recently updated September 13th 2023. This study aims to enrol 30 patients from a single site."
What aims does this medical experiment seek to accomplish?
"The purpose of this research is to assess the acceptability of the intervention over a timeframe which includes Pre-Intervention, Mid-Intervention (3 weeks after start), Post Intervention (6 weeks after baseline) and 1.5 and 3 month follow ups. Secondary outcomes are measured via Generalized Anxiety Disorder-7 Questionnaire, Death Attitude Profile - Revised, Fear of Death & Death Avoidance Scales and Hopelessness Assessment in Illness Questionnaire 8 item tests; each having their own scoring system ranging between 0 to 21, 12 to 84 and 0 to 16 respectively with higher scores indicating greater symptoms being tested for."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger